| 2023-12-19 | BioAtla, Inc. BCAB | director | 20,000 0.0427% | $2.05 | $41,048 | +21.26% | ||
| 2023-06-01 | 180 Life Sciences Corp. ATNF | director | 18,000 0.4949% | $1.23 | $22,068 | -75.14% | ||
| 2021-12-09 | 180 Life Sciences Corp. ATNF | director | 5,000 15.7263% | $4.27 | $21,350 | -68.88% | ||
| 2021-11-02 | Sale | BioAtla, Inc. BCAB | director | 900 0.0027% | $30.00 | $27,000 | -77.38% | |
| 2021-09-15 | Sale | BioAtla, Inc. BCAB | director | 900 0.0027% | $36.82 | $33,138 | -79.67% | |
| 2021-08-16 | Sale | BioAtla, Inc. BCAB | director | 900 0.0027% | $40.60 | $36,540 | -81.26% | |
| 2021-07-15 | Sale | BioAtla, Inc. BCAB | director | 900 0.0027% | $38.29 | $34,461 | -64.62% | |
| 2005-03-02 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 8,000 0.0221% | $41.10 | $328,829 | +15.69% | |
| 2004-09-15 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 4,000 0.0108% | $50.25 | $201,018 | -11.12% |